Facebook and Twitter have taken down hundreds of Iranian accounts that attempted to mislead users
The social networks have removed content related to an Iranian political misinformation campaign.
The news: Last night, Facebook announced it has removed 652 fake users and pages related to Iranian and Russian efforts to mislead users. The efforts originating from Iran dated back to 2011 and were targeted at a variety of areas including the Middle East, Latin America, Britain, and the US. Soon after, Twitter followed suit and took down 284 accounts also associated with Iran.
Again? Last month Facebook removed another 32 users and pages related to Russian efforts to influence politics ahead of the 2018 midterm elections. Despite these continued reports, according to Pew, only 15 percent of Russians believe their country interfered in the 2016 US election.
Why now? The platform’s increased diligence in removing these accounts and reporting them publicly is due to public scrutiny of whether it can avoid the issues of foreign influence that affected the 2016 election.
Why it matters: Although the removal echoes other incidents recently, it is distinct in two respects. First, the misinformation campaigns targeted several countries, not just the US, and second, Iran has been revealed as a significant new source of misinformation. Fake news, it turns out, is going global in a big way.
Keep Reading
Most Popular

Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.